News FDA approves Adstiladrin as first gene therapy for NMIBC The US Food and Drug Administration (FDA) has
News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
News Support bot for cancer patient relatives wins WHO Health Hac... A bot that provides support to relatives of people with cancer – called Scally – has been named the winner of the World Hea
Views & Analysis At ESMO 2022, oncologists saw exciting cancer advances Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.
Events Partner Content 6th Antifibrotic Drug Development Summit Only cross-disease, cross-organ fibrosis summit
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
